← Back to patent-cliff list

CAS 917022-13-0

tert-butyl (((1r,4r)-4-(((4-amino-6-chloropyrimidin-2-yl)amino)methyl)cyclohexyl)methyl)(3-((tert-butoxycarbonyl)(cyclohexyl)amino)propyl)carbamate

Codes: BURIX-011

Application context (from source-drug indications)

Haematopoietic stem cell transplantationBurixafor HydrobromideProstate cancerBurixafor HydrobromideAcute myeloid leukaemiaBurixafor HydrobromideMultiple myelomaBurixafor HydrobromideNon-Hodgkin lymphomaBurixafor HydrobromideHodgkin's diseaseBurixafor Hydrobromide

Source drugs (routes using this intermediate)

DrugTierExpiry
Burixafor HydrobromideTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.